DK3674307T3 - Makrocyklus indeholdende aminopyrazol og pyrimidin og farmaceutisk sammensætning og anvendelse deraf - Google Patents
Makrocyklus indeholdende aminopyrazol og pyrimidin og farmaceutisk sammensætning og anvendelse deraf Download PDFInfo
- Publication number
- DK3674307T3 DK3674307T3 DK18849368.8T DK18849368T DK3674307T3 DK 3674307 T3 DK3674307 T3 DK 3674307T3 DK 18849368 T DK18849368 T DK 18849368T DK 3674307 T3 DK3674307 T3 DK 3674307T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimidine
- pharmaceutical composition
- macrocycle containing
- aminopyrazole
- containing aminopyrazole
- Prior art date
Links
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical compound NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 title 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 150000002678 macrocyclic compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710728132 | 2017-08-23 | ||
| PCT/CN2018/101960 WO2019037761A1 (zh) | 2017-08-23 | 2018-08-23 | 含有氨基吡唑并嘧啶的大环化合物及其药物组合物和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3674307T3 true DK3674307T3 (da) | 2023-09-11 |
Family
ID=65439377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18849368.8T DK3674307T3 (da) | 2017-08-23 | 2018-08-23 | Makrocyklus indeholdende aminopyrazol og pyrimidin og farmaceutisk sammensætning og anvendelse deraf |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11098060B2 (da) |
| EP (1) | EP3674307B1 (da) |
| JP (1) | JP7239563B2 (da) |
| KR (1) | KR102619444B1 (da) |
| CN (2) | CN110945000B (da) |
| AU (1) | AU2018320021C1 (da) |
| BR (1) | BR112020003783A2 (da) |
| CA (1) | CA3071032A1 (da) |
| DK (1) | DK3674307T3 (da) |
| ES (1) | ES2951427T3 (da) |
| FI (1) | FI3674307T3 (da) |
| MX (1) | MX2020001979A (da) |
| PL (1) | PL3674307T3 (da) |
| WO (1) | WO2019037761A1 (da) |
| ZA (1) | ZA202001442B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102447084B1 (ko) * | 2017-11-10 | 2022-09-23 | 앤젝스 파마수티컬, 인크. | Trk 키나제 억제제로서의 거대 고리 화합물 및 그의 용도 |
| EP3770161B1 (en) | 2018-04-16 | 2022-08-24 | Shenzhen TargetRx, Inc. | Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity |
| AU2019364336B2 (en) | 2018-10-22 | 2023-11-16 | Alumis Inc. | TYK2 inhibitors and uses thereof |
| CN113727984B (zh) * | 2019-05-21 | 2024-03-15 | 浙江海正药业股份有限公司 | 大环类衍生物、及其制备方法和用途 |
| CN112110938B (zh) * | 2019-06-21 | 2021-11-09 | 成都海博为药业有限公司 | 一种作为蛋白质激酶抑制剂的化合物及其制备方法和用途 |
| CN111875620B (zh) * | 2020-09-28 | 2020-12-11 | 上海美迪西生物医药股份有限公司 | 吡唑并嘧啶类大环衍生物及其应用 |
| CN114907379A (zh) * | 2021-02-06 | 2022-08-16 | 正大天晴药业集团股份有限公司 | 作为egfr激酶抑制剂的大环化合物 |
| CN113475740B (zh) * | 2021-07-10 | 2022-10-21 | 深圳市真味生物科技有限公司 | 一种手性合成尼古丁的制备方法 |
| CN117597128A (zh) * | 2021-08-23 | 2024-02-23 | 正大天晴药业集团股份有限公司 | 含有氨基的大环化合物在治疗trk激酶介导的肿瘤中的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2350075T1 (sl) | 2008-09-22 | 2014-06-30 | Array Biopharma, Inc. | Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji |
| SG10201914059WA (en) | 2008-10-22 | 2020-03-30 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors |
| EP2918588B1 (en) * | 2010-05-20 | 2017-05-03 | Array Biopharma, Inc. | Macrocyclic compounds as TRK kinase inhibitors |
| JP5959541B2 (ja) | 2011-02-25 | 2016-08-02 | ノバルティス アーゲー | Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン |
| RU2732405C2 (ru) | 2015-07-02 | 2020-09-16 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ |
| CN108137607B (zh) | 2015-08-26 | 2021-04-06 | 缆图药品公司 | 适用于治疗与ntrk相关的病症的化合物和组合物 |
| PT3533796T (pt) * | 2016-10-28 | 2021-11-18 | Lianyungang Runzhong Pharmaceutical Co Ltd | Composto de amino pirazolopirimidina utilizado como inibidor do recetor do fator neurotrófico tirosina quinase |
-
2018
- 2018-08-23 BR BR112020003783-4A patent/BR112020003783A2/pt unknown
- 2018-08-23 ES ES18849368T patent/ES2951427T3/es active Active
- 2018-08-23 PL PL18849368.8T patent/PL3674307T3/pl unknown
- 2018-08-23 JP JP2020511268A patent/JP7239563B2/ja active Active
- 2018-08-23 FI FIEP18849368.8T patent/FI3674307T3/fi active
- 2018-08-23 MX MX2020001979A patent/MX2020001979A/es unknown
- 2018-08-23 CN CN201880053972.3A patent/CN110945000B/zh active Active
- 2018-08-23 AU AU2018320021A patent/AU2018320021C1/en active Active
- 2018-08-23 US US16/641,187 patent/US11098060B2/en active Active
- 2018-08-23 KR KR1020207008187A patent/KR102619444B1/ko active Active
- 2018-08-23 CA CA3071032A patent/CA3071032A1/en active Pending
- 2018-08-23 DK DK18849368.8T patent/DK3674307T3/da active
- 2018-08-23 CN CN202111098325.4A patent/CN113735881A/zh active Pending
- 2018-08-23 WO PCT/CN2018/101960 patent/WO2019037761A1/zh not_active Ceased
- 2018-08-23 EP EP18849368.8A patent/EP3674307B1/en active Active
-
2020
- 2020-03-06 ZA ZA2020/01442A patent/ZA202001442B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102619444B1 (ko) | 2023-12-29 |
| RU2020108770A (ru) | 2021-09-23 |
| EP3674307A4 (en) | 2021-04-28 |
| AU2018320021C1 (en) | 2023-02-23 |
| CN113735881A (zh) | 2021-12-03 |
| CA3071032A1 (en) | 2019-02-28 |
| CN110945000B (zh) | 2021-09-03 |
| ES2951427T3 (es) | 2023-10-20 |
| MX2020001979A (es) | 2020-03-24 |
| RU2020108770A3 (da) | 2022-02-28 |
| BR112020003783A2 (pt) | 2020-09-01 |
| AU2018320021B2 (en) | 2022-04-21 |
| JP7239563B2 (ja) | 2023-03-14 |
| AU2018320021A1 (en) | 2020-03-12 |
| EP3674307A1 (en) | 2020-07-01 |
| WO2019037761A1 (zh) | 2019-02-28 |
| KR20200044062A (ko) | 2020-04-28 |
| CN110945000A (zh) | 2020-03-31 |
| US20200291042A1 (en) | 2020-09-17 |
| ZA202001442B (en) | 2022-04-28 |
| FI3674307T3 (fi) | 2023-09-11 |
| US11098060B2 (en) | 2021-08-24 |
| JP2021501738A (ja) | 2021-01-21 |
| EP3674307B1 (en) | 2023-06-07 |
| PL3674307T3 (pl) | 2023-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3674307T3 (da) | Makrocyklus indeholdende aminopyrazol og pyrimidin og farmaceutisk sammensætning og anvendelse deraf | |
| EP3749311A4 (en) | PEMETREXED POLYGLUTAMATE GAMMA COMPOSITIONS AND THEIR USES | |
| SI3658557T1 (sl) | Zaviralci TYK2 in njihova uporaba | |
| MA44627A (fr) | Inhalateur mobile et récipient s'utilisant conjointement | |
| SG11202003320SA (en) | Dihydropyrimidine compounds and uses thereof in medicine | |
| DK3280433T3 (da) | De novo-bindingsdomæneindeholdende polypeptider og anvendelser deraf | |
| SI3681872T1 (sl) | Heteroaril substituirani beta-hidroksietilamini za uporabo v zdravljenju hiperglikemije | |
| DK3215511T3 (da) | Substituerede pyrazolo(1,5-a)pyrimidiner og deres anvendelse i behandlingen af medicinske lidelser | |
| ZA201905020B (en) | Pyrimidine compound and pharmaceutical use thereof | |
| AP2016009487A0 (en) | Novel pyrazolo pyrimidine derivatives and their use as malt1 inhibitors | |
| EP3415518A4 (en) | MACROCYCLUS AND COMPOSITION THEREOF | |
| EP3728270A4 (en) | MACROCYCLIC KINASE INHIBITORS AND THEIR USES | |
| IL246630B (en) | History of pyrimidine pyrazolyl and pharmaceutical preparations containing them | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| IL278973A (en) | New benzodiazepine histories and uses | |
| ZA202000238B (en) | Sost antibody pharmaceutical composition and uses thereof | |
| ZA201900421B (en) | Novel quinazolinone derivatives inhibiting pi3k and pharmaceutical composition containing same | |
| EP3541378A4 (en) | ALLOSTERIC ANTAGONISTS OF GPRC6A AND THEIR USE IN THE MITIGATION OF PROTEINOPATHIES | |
| ZA201905402B (en) | Compounds and their use in the treatment of schistosomiasis | |
| EP3466269A4 (en) | COMPOSITION CONTAINING CAFFEINE AND CYCLOALANYLALANINE | |
| DK3412664T3 (da) | Heterocyklisk sulfonamidderivat og medicin indeholdende samme | |
| SG11202010985TA (en) | Heterocyclic derivatives and use thereof | |
| IL254152B (en) | Pyrimidine derivatives as kinase inhibitors and their medicinal uses | |
| IL265923A (en) | Modified 6-(h1-pyrazol-1-yl)pyrimidin-4-amine histories and their uses | |
| EP3551632C0 (en) | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS |